BioSpace News Archive

Streamlined solution features quality control reagent kits, robotic sample preparation, mass spectrometry analysis and data reporting software to transform analysis efficiency WALTHAM, Mass.--( BUSINESS WIRE )-- PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today launched the cannabis industry’s first fully-automated liquid handling sample preparation and LC/MS/MS analysis workflow for pesticide residue testing

October is ADHD Awareness Month, and retired NFL linebacker J.T. Thomas wants people to know that it is okay to get help for the treatment of attention deficit hyperactivity disorder (ADHD).

ILC Therapeutics , a Scottish biotech company, has announced that its unique synthetic Interferon called Alfacyte™ is fifteen to twenty times more effective at preventing the spread of SARS-CoV-2 (the virus which causes COVID-19) in cell culture than other commercially-available Interferons such as Interferon alpha 2 and Interferon beta 1a. COVID-19 tries to slow down the body’s innate Interferon response to viral infe

Veeva Systems (NYSE: VEEV) today announced the first two applications built on the Veeva Clinical Network, the industry’s only solution that links sponsors, clinical research sites, and patients for paperless, patient-centric trials. Veeva Site Connect connects sponsors and clinical research sites

Riverview Health Emergency Room & Urgent Care will open its third combined, freestanding emergency room and urgent care facility in Hamilton County in West Carmel/Zionsville on Monday, Oct. 19 at 7 a.m.

In preclinical studies, Salicyn-30, a small molecule, demonstrated potent in-vitro viral load reduction of 3-4 log in SARS-CoV-2 infection model in normal healthy VERO E6 cells. Salicyn-30 displays a novel mechanism of inhibition of SARS-CoV-2, with potential additive benefits when used in a multi-modal therapy approach. Salicyn-30 can potentially be administered orally alone and will be tested in combination with Sorrento’s potent STI-1499 and affinity matured STI-2020 neutralizing antibo

On September 23rd, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the first serology (antibody) Point-Of-Care (POC) test for COVID-19.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced call-in details for tomorrow’s investor conference call on Thursday October 8, 2020 at 8: 0 0 AM Eastern time . The access information for the investor conference call is as follows: Domestic US/Canada – 1 - 877-830-2587 Direct Toll / International - 1- 785-424-1734 Program Title: NuGenerex Immuno- Oncology - Investor Conference Call Conference I

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that its Chief Medical Officer, Douglas W. Losordo, M.D., FACC, FAHA, will present at the Alliance for Regenerative Medicine’s (ARM) Cell and Gene Meeting on the Mesa, being held virtually on October 12-16, 2020. T

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced it will report its financial results for the third quarter and nine months ended September 30, 2020 after the stock market closes on Wednesday, November 4, 2020. Hanger’s management team will host a conference call with the financial community to discuss the financial results the following morni